The current study advances the field by demonstrating that Ac-SDKP has an anti-fibrotic effect on silicosis in vivo and in vitro, an effect that involves inhibition of TGF-β induced myofibroblast differentiation, leading to a decrease in SRF, α-SMA and ECM deposition. This evidence concerns the gene ACTA1 and silicosis.